Abstract-Stem cell antigen (Sca) 1, a glycosyl phosphatidylinositol-anchored protein localized to lipid rafts, is upregulated in the heart during myocardial infarction and renovascular hypertension-induced cardiac hypertrophy. It has been suggested that Sca-1 plays an important role in myocardial infarction. To investigate the role of Sca-1 in cardiac hypertrophy, we performed aortic banding in Sca-1 cardiac-specific transgenic mice, Sca-1 knockout mice, and their wild-type littermates. Cardiac hypertrophy was evaluated by echocardiographic, hemodynamic, pathological, and molecular analyses. Sca-1 expression was upregulated and detected in cardiomyocytes after aortic banding surgery in wild-type mice. Sca-1 transgenic mice exhibited significantly attenuated cardiac hypertrophy and fibrosis and preserved cardiac function compared with wild-type mice after 4 weeks of aortic banding. Conversely, Sca-1 knockout dramatically worsened cardiac hypertrophy, fibrosis, and dysfunction after pressure overload. Furthermore, aortic banding-induced activation of Src, mitogen-activated protein kinases, and Akt was blunted by Sca-1 overexpression and enhanced by Sca-1 deficiency. Our results suggest that Sca-1 protects against cardiac hypertrophy and fibrosis via regulation of multiple pathways in cardiomyocytes. Key Words: stem cell antigen 1 Ⅲ cardiac hypertrophy Ⅲ fibrosis Ⅲ Src Ⅲ MAPK Ⅲ Akt C ardiac hypertrophy occurs when the heart experiences elevated workload or injury. Although it is an adaptive response to reduce ventricular wall stress and initially maintain output, sustained hypertrophy leads to ventricular dysfunction and, ultimately, heart failure.1 Left ventricular hypertrophy has been considered to be a maker of increased risk of adverse cardiovascular events.2 The signaling mechanisms involved in the hypertrophic response are complex, including cell surface receptors, signal transduction pathways, and transcriptional and posttranscriptional regulation.3 However, the molecular mechanisms have not been clearly elucidated. A better understanding of the factors that regulate hypertrophic pathways could reveal potential therapeutic targets for treating cardiac hypertrophy and heart failure. Stem cell antigen (Sca) 1 is an 18-kDa glycosyl phosphatidylinositol-anchored protein (GPI-AP) in mice that was originally identified as an antigen upregulated in activated lymphocytes and also named lymphocyte activation protein-6A, as a member of the Ly6 gene family.5 GPI-APs are primarily associated with lipid rafts enriched in sphingolipids and cholesterol, which is important for GPI-APs in signal transduction. 6 The proteins localized in the lipid raft include GPI-APs, Src family kinases, low molecular weight and heterotrimeric G proteins, and various receptor tyrosine kinases. 7,8 Previous studies have shown that inhibition of Sca-1 expression causes the disinhibition of the Src family kinase Fyn, 9 and mutations in Sca-1 and Src family kinases often lead to opposing phenotypes in mice, indicating that Sca-1 serves as a nega...